Intracranial hypertension syndrome in systemic lupus erythematosus: Clinical analysis and review of the literature

Abstract

In order to better understand the clinical manifestation of systemic lupus erythematosus (SLE) with intracranial hypertension syndrome (IHS), we analyzed the clinical features and treatment of a typical SLE patient with IHS. SLE is one of the most unpredictable autoimmune diseases involving multiple organ systems that is defined clinically and associated with antibodies directed against cell nuclei. IHS is an uncommon manifestation of neuropsychiatric SLE (NPSLE) and is characterized by an elevated intracranial pressure, papilledema, and headache with occasional abducens nerve paresis, absence of a space-occupying lesion or ventricular enlargement, and normal cerebrospinal fluid chemical and hematological constituents. IHS has been reported in a few sporadic cases in patients with SLE worldwide, but rarely has been reported in China. In this study, a 34-year-old female SLE patient with IHS was reported and pertinent literature reviewed. The clinical presentation, image logical features, and investigatory findings were discussed.

Keywords

systemic lupus erythematosus / intracranial hypertension syndrome / central nervous system / clinical analysis

References

[1] CastellinoG., GovoniM., GiacuzzoS., et al. . Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev, 2008, 7(4): 297-304

[2] StojanovichL., Zandman-GoddardG., PavlovichS., et al. . Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev, 2007, 6(6): 421-426

[3] OgawaM., IshimaruK., ShirotoT., et al. . A case of benign intracranial hypertension associated with systemic lupus erythematosus (SLE) showing diffuse white matter lesions on MRI. Rinsho Shinkeigaku, 1994, 34(6): 577-581

[4] AmitM., MoladY., LevyO., et al. . Headache in systemic lupus erythematosus and its relation to other disease manifestations. Clin Exp Rheumatol, 1999, 17: 467-470

[5] EdworthyS.M.. HarrisE. D.. Clinical Manifestations of Systemic Lupus Erythematosus. Kelley’s Textbook of Rheumatology, 20057th EditionUSA, Saunders: 1201-1224

[6] TanE.M., CohenA.S., FriesJ.F., et al. . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25(11): 1271

[7] HanlyJ.G., UrowitzM.B., Sanchez-GuerreroJ., et al. . Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Nat Clin Pract Rheumatol, 2007, 3(8): 428-429

[8] SannaG., PigaM., PeltyM.T., et al. . Central nervous involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus, 2000, 9(8): 573-583

[9] LeeH.S., BaeS.C., UhmW.S., et al. . Red ear(s) syndrome associated with child neuropsychiatric lupus erythemaytosus. Lupus, 2000, 9(4): 301-303

[10] SibbittW.L., SaibbitR.R., BrooksW.M., et al. . Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum, 1999, 42(10): 2026-2038

[11] SteensS. C. A., BosmaG. P., CateR. T., et al. . A neuroimaging follow up study of a patient with juvenile central nervous system lupus erythematosus. Ann Rheu Dis, 2003, 52(6): 583-586

[12] KuyucuS., ArginA., KuyucuN., et al. . Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association. Turk J Pediatr, 2007, 49(1): 98-101

[13] ACR Ad Hoc Committee on neuropsychiatric lupus nomenclature.. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum, 1992, 42: 599-608

[14] ZhouH., ZhangF., TianX., et al. . Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus, 2008, 17(2): 93-99

[15] GovoniM., CastellinoG., PadovanM., et al. . Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus, 2004, 13(3): 149-158

[16] TrysbergE., BlennowK., ZachrissonO., et al. . Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther, 2004, 6: R551-R556

[17] NiJ., GaoS., WuQ.J., et al. . Myelopathy associated with systemic lupus erythematosus in 6 cases. Chin J Neuroimmunol Neurol (Chinese), 2006, 13(5): 294-298

[18] SannaG., BertolacciniM.L., MathieuA.. Central nervous system lupus: a clinical approach to therapy. Lupus, 2003, 12(12): 935-942

[19] TraynorA.E., SchroederJ., RosaR.M., et al. . Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and hematopoietic stem-cell transplantation: a phase I study. Lancet, 2000, 356: 701-707